It’s common for companies to do a bad deal. It’s less common for them to admit as much and reverse tack after just two years, writes KarenKKwok
in August 2020. Nestlé originally touted potential annual sales of $1 billion for the drug, which had received U.S. Food and Drug Administration approval. But on Tuesday the Swiss consumer-goods giant said uptake had been slow among patients and doctors.
Nestlé Chief Executive Mark Schneider can arguably afford to be honest, rather than trying to bury the M&A flop within his $330 billion behemoth. That’s because his overall acquisition strategy seems to be working. Nestlé says it has bought companies with a total enterprise value of more than $50 billion since 2017, with 83% by value either achieving or exceeding the company’s acquisition plans.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Breakingviews - Breakingviews: Protests leave China facing a terrible trilemmaOfficials’ muddled response to spiking Covid cases has set off three consecutive days of demonstrations spanning cities and social classes. The government, having wasted two years prematurely congratulating itself for fending off the pandemic, is now unprepared to address the interrelated economic, health, and political crises resulting from its overconfidence.
Les mer »
Scooplet: Nestlé to debut plant-based chocolate chipsPlant-based Toll House morsels will likely hit shelves in 2023.
Les mer »
Breakingviews - China decoupling takes one step forward, one backWealthy democracies want to cut their reliance on China. The People's Republic too has moved to become more self-sufficient. Tariffs, sanctions and suspicion have redirected flows of human and financial capital, and this week’s political protests in China may accelerate the trend. But decoupling remains more a geopolitically driven aspiration than economic fact.
Les mer »
Breakingviews - Brenntag’s U.S. swoop is both logical and riskyGerman chemical distributor Brenntag is eyeing $5 billion U.S. rival Univar Solutions . A deal would offer the $10 billion group scale in a fragmented market, and greater exposure to North America. But it also carries risks.
Les mer »
Breakingviews - Protests leave China facing a terrible trilemmaChinese officials’ muddled response to spiking Covid cases has set off three consecutive days of demonstrations spanning cities and social classes. The government, having wasted two years prematurely congratulating itself for fending off the pandemic, is now unprepared to address the interrelated economic, health, and political crises resulting from its overconfidence.
Les mer »
Breakingviews - Venezuelan oil offers little to U.S. or ChevronU.S. President Joe Biden is open to Venezuelan oil. Over the weekend, the Treasury Department issued $355 billion oil giant Chevron a license to resume limited production in the country. That helps to spread around extraction of the fossil fuel, and could ease prices on the margin. But between the dirty Venezuelan oil and decrepit fields, the help is limited.
Les mer »